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Abstract:  
Manganese (Mn) and iron (Fe) are both paramagnetic species that can affect magnetic resonance relaxation 
rates. They also share common transport systems in vivo and thus in experimental models of metal exposure 
their effects on relaxation rates may interact in a complex fashion. Here we present a novel model to interpret 
the combined effects of Mn and Fe on MRI relaxation rates. To achieve varying levels of both metals, adult rats 
were separated into four groups; a control group and three groups treated with weekly intravenous injections of 
3 mg Mn/kg body for 14 weeks. The three treated groups were fed either a normal diet, Fe deficient or Fe 
enriched diet. All rats were scanned using MRI at the 14th week to measure regional water relaxation rates. Rat 
brains were removed at the end of the study (14th week) and dissected into regions for measurement of Mn and 
Fe by atomic absorption spectroscopy. For the normal diet groups, R1 was strongly correlated with tissue Mn 
concentrations. However, the slopes of the linear regression fits varied significantly among different brain 
regions, and a simple linear model failed to explain the changes in relaxation rate when both Mn and Fe 
contents changed. We propose a competition model, which is based on the ability of Mn and Fe to compete in 
vivo for common binding sites. The combined effect of Mn and Fe on the relaxation rates is complicated and 
additional studies will be necessary to explain how MRI signals are affected when the levels of both metals are 
varied.  
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Article: 
INTRODUCTION 
Magnetic resonance imaging (MRI) is a non-invasive diagnostic imaging technique with potential applications 
for measuring and monitoring the effects of metal exposure and neurotoxicity. MR images are sensitive to the 
presence of paramagnetic ions, which increase the relaxation rates of tissue water protons and, in principle, 
measurements of tissue relaxation rates may be used to monitor tissue metal levels quantitatively. Divalent 
manganese  (Mn) and iron (Fe) ions (Mn
2+
 and Fe
2+
), and trivalent Fe ion (Fe
3+
), contain unpaired electrons and 
are consequently highly effective as paramagnetic relaxation agents capable of shortening both the T1 and T2 
relaxation times of water molecules (1 –5). 
 
Mn and Fe are both essential metals for metabolism and biochemical functions in the central nervous system. 
Mn is an essential nutrient found in many foods, and is required for proper growth and development. It is an 
important component of many key enzymes involved in the detoxification of reactive oxygen species, amino 
acid synthesis and energy production (6,7). Both deficiency and excess of this metal may result in health 
problems, although Mn toxicity is more common. Too little dietary Mn can lead to growth retardation, 
alterations in glucose and high-density lipoprotein (HDL) levels and even reproductive failure (8). On the other 
hand, excess Mn can lead to the onset of a movement disorder, termed ‘manganism,‖ which is similar to 
Parkinson’s disease. Fe is also involved in a variety of critical metabolic processes such as DNA synthesis, 
oxygen and electron transport, dopamine and serotonin synthesis, and myelin formation (9–11). Furthermore, it 
has been suggested that brain Fe content is critical for proper cognitive development and behavior (12,13). 
Increased total brain Fe content is associated with neurodegenerative disorders such as Alzheimer’s and 
Parkinson’s diseases (12), while Fe deficiency can also lead to developmental and intellectual retardation 
(12,14). 
 
The precise mechanisms by which Mn and Fe are delivered into the brain, and how Mn and Fe affect each 
other’s disposition, are not clear. Mn and Fe share similar transporter systems that allow the metals to enter cells 
(e.g., transferrin, divalent metal transporter-1) (15). When the concentrations of the metals are high, there may 
be competition for the transporter or other targets between the ions so that changes in one metal may influence 
the distribution of the other. For example, Zheng et al. found that brain Fe metabolism was changed in rats 
exposed to high doses of Mn (16). Fe deficiency leads to increased Mn accumulation in the brain (17,18), while 
high Fe in the diet may decrease Mn absorption (19,20). There is also evidence that Mn and Fe may enter the 
brain through independent transport systems (21–26). It is well know that, in simple solutions, the water NMR 
relaxation rates (R1 and R2) are directly proportional to the concentration of paramagnetic ion. This simple 
linear relationship has been widely used to estimate tissue levels of Mn or Fe alone using MRI (27–31). 
However, Mn and Fe are both paramagnetic, and they may compete or affect each other in biological systems. 
Thus the relationship between water relaxation rates and the concentrations of these paramagnetic ions together 
may not be as simple as assumed by the linear model. A more complex model may be needed to address the 
interaction between Mn and Fe binding and storage systems, and their combined effects on water relaxation 
times. 
 
To address these questions, and to illustrate the need for more sophisticated analyses of imaging data, we 
studied the variations in MR relaxation rates as a function of metal content in groups of rats subjected to 
different combinations of dietary Fe and intravenous Mn. Our goal was to induce varying levels of both metals 
and to use quantitative MRI relaxometry to determine the Mn deposition pattern in different brain regions in 
rats exposed to this metal. In attempting to relate MR relaxation changes to tissue metal levels, we have 
developed a model that incorporates competitive mechanisms between the metal ions. Such a model is essential 
to explain our relaxation measurements. 
 
MATERIALS AND METHODS 
Animals 
In order to achieve variable levels of Mn and Fe in tissues, adult male Sprague–Dawley rats were randomly 
separated into four groups; control (CN, n = 5), Mn treated (MnT, n = 6), Fe deficient and Mn treated 
(FeDMnT, n = 6), Fe supplemented and Mn treated (FeSMnT, n = 4) groups. MnT, FeDMnT, FeSMnT groups 
were given weekly intravenous (through tail vein) injections of a sterile isotonic Mn
2+
 solution (MnCl2) 
equivalent to 3 mg Mn/kg body weight for a total of 14 weeks. This corresponds to doses of Mn comparable to 
those acquired by humans exhibiting symptoms of Mn intoxication (32). CN and MnT were maintained on a 
normal diet (30 mg Fe/kg chow, BioServe, Frenchtown, NJ, USA), while the FeDMnT and FeSMnT groups 
were given Fe deficient (3 mg Fe/kg feed; BioServe) or Fe supplemented (300 mg Fe/kg feed; BioServe) food, 
respectively. Food for all groups of rats has 12 mg Mn/kg chow. Fe in the Fe-supplemented diet (FeSMnT) was 
in the form of ferric citrate. Rats had free access to food and water throughout the study and were weighed 
weekly to monitor their general health. All procedures were in compliance with and approved by the 
Institutional Animal Care and Use Committee of Vanderbilt University. 
 
MRI 
Animals were scanned at the 14th week (24h after the last Mn injection). All experiments were acquired using a 
4.7T, 31-cm-horizontal-bore Varian INOVA magnet (Varian, Inc., Palo Alto, CA, USA) with actively shielded 
gradients (40G/cm, rise times full amplitude of 130 μs) and a 63 mm transmit/receive quadrature imaging 
volume coil. Rat brains were scanned from both axial (FOV = 40 x 40 mm, 30 slices) and coronal (FOV = 40 x 
50 mm, 20 slices) directions with 0.75 mm slice thickness. 
 
Before the imaging procedure, animals were first anesthetized with isoflurane (2%) and placed in a stereotaxic 
support cradle with the head secured. The cradle was then put in the volume coil to make sure the head of the 
animal was located at the center of the coil. Isoflurane was lowered to 1.5–1.75% and was maintained 
throughout the imaging experiment. Temperature (36.5–37.5 °C) of the animal was monitored (SA Instruments, 
Stony Brook, NY, USA) and maintained via a flow of warm air which is controlled by a rectal temperature 
probe (SA Instruments). Respiration rates were externally monitored and maintained at 50–70 breaths per 
minute throughout the imaging session. 
 
T1 was measured using 2-D Fast Low Angle Shot sequences (FLASH) and different flip angles with parameters 
as follows: TR/ TE = 489/6.59 ms; flip angle = 10, 30, 55, 70; 2 acquisitions. The image matrix was 256 x 256. 
T2 was measured using a multislice fast spin echo (FSE) sequence: TR = 5100 ms; Echo train length = 8; k-
space center = 4; echo spacing = 5, 6.7, 10, 13, 15ms; 2 acquisitions; Image matrix = 128 x 128. 
 
T1 and T2 maps were calculated by fitting the series of T1 and T2 dependent images to the appropriate 
theoretical expressions using 2 parameter least squares fits. The parametric maps were then coregistered to a 
high resolution rat template and resliced using SPM (http://www.fil.ion.ucl.ac.uk/spm). Based on the rat brain 
template, multislice regions of interest (ROIs) were chosen for seven brain regions including cerebellum, 
brainstem, midbrain, striatum, hippocampus and cortex. Averaged T1 and T2 values within each of the ROIs 
were calculated for each rat and used in further analyses. 
 
 
Multiple MnCl2 phantoms with similar T1 and T2 values as the rat brain tissues were also made (pH 7). Their T1 
and T2 values were measured at 37 °C using an inversion recovery method and by changing TE in a spin echo 
sequence respectively. 
 
Graphite furnace atomic absorption spectroscopy (GFAAS) 
At the conclusion of the study, the animals were euthanized and their brains were removed, dissected (into 
cerebellum, brainstem, midbrain, striatum, hippocampus, and cortex), weighed and quick frozen. Tissue Mn and 
Fe were measured in these regions with GFAAS (Varian AA240, Varian, Inc.). Brain regions were digested in 
ultrapure nitric acid (1:10 w/v dilution) for 48–72 h in a sandbath (60 °C). An aliquot of 100 μl of digested 
tissue was brought to 1 ml total volume with 2% nitric acid and analyzed for Mn and Fe. Both Mn and Fe 
GFAAS analyses were performed at the same time in the same sample. The standards used to standardize the 
GFAAS were purchased from Acros Organics, Morris Plains, NJ, USA: Mn (#19611-1000) and Fe (#19605-
1000). Bovine Liver Standard (National Bureau of Standards, Washington, DC) was used as external standard 
in every analysis. 
 
Statistical analysis 
Levene’s homogeneity-of variance test was first applied to test if the variances are equal across groups (p < 
0.05). One-way ANOVA was used to determine if differences exist among the group means at an alpha level of 
0.05. If significant difference was detected among the means, post-hoc range tests (Tukey HSD if variances are 
equal across groups, Dunnett T3 if variances are unequal across groups) were then applied to test the difference 
between each pair of means at an alpha level of 0.05. All statistical analyses were performed with SPSS 
software (SPSS, Inc., Chicago, IL, USA). 
 
RESULTS 
Experiment results 
Ion concentrations measured by GFAAS 
Averaged metal concentrations at six brain regions which were measured by GFAAS at the 14th week for the 
four groups of rats are summarized in Table 1a (Mn concentration) and Table 1b (Fe concentration). One-way 
ANOVA and post-hoc range tests were used to compare Mn and Fe levels in each brain region across groups 
(see details in Materials and Methods Section). 
 
Brain Mn levels were statistically significantly higher in the cerebellum and brainstem for all treated animals 
(MnT, FeDMnT, and FeSMnT) compared to CN (p < 0.05). Other brain regions showed differential metal 
dysregulation compared to CN animals. For example, Mn content was increased in the hippocampus of MnT 
animals (p < 0.01), but decreased in animals receiving FeDMnT chow (p < 0.05). Additionally, cortical Mn 
concentrations were greater in FeDMnT and FeSMnT (p < 0.05) compared to control animals, while MnT 
animals had cortical Mn concentrations similar to CN. 
 
Brain Fe content was also determined at the conclusion of the study. No significant change in Fe concentration 
was observed between the CN and MnT groups in any of the examined brain regions (Table 1 b). Brain Fe 
levels were also indistinguishable in animals receiving Fe-modified diets regardless of whether animals were 
FeD or FeS chow. Additionally, cerebellar Fe was statistically significantly lower in FeSMnT and FeDMnT 
animals compared to either CN or MnT (p < 0.05). No differences in Fe concentrations were observed in the 
hippocampus, midbrain or striatum among the four groups. Finally, the FeDMnT group demonstrated a 
statistically significant decrease in Fe deposition in the cortex relative to MnT (p < 0.05), and in the cerebellum 
and brainstem compared to both the MnT and CN (p < 0.05 for both groups). 
 
Relaxation rates measured by MRI 
Typical axial and coronal T1 weighted images of control and Mn-treated rats at week 14 are presented in Fig. 1 
(1st and 2nd columns of Fig. 1a and b). Pronounced signal increases are apparent in specific brain regions, such 
as the pontine nuclei (pons) (Fig. 1a, first and second rows, white arrow), dentate gyrus (Fig. 1b, black arrow 
and circle) and habenula (Fig. 1a, fourth row, white arrow). The contrast of T1-weighted images was increased 
in brain regions, such as hippocampus (Fig. 1a, black arrow), pontine nuclei (Fig. 1a, first and second rows, 
white arrow), cerebellum (CB) (Fig. 1b, 3rd row) and olfactory bulb (OB) (Fig. 1b, 4th row), allowing clear 
visualization of anatomic details of the brain neuroarchitecture. The CA3 layer of hippocampus, as well as 
layers of olfactory bulb was also clearly distinguishable in Mn treated rats due to the signal and contrast 
enhancement. Improved gray-white matter contrast was also apparent in the cerebellum. These increases in T1 
weighted signal and contrast were similar to those previously reported (4,33,34). 
 
As seen in the T1-weighted images (3rd and 4th columns of Fig. 1a,b), the signal and contrast enhancement 
effects in the FeDMnT and FeSMnT groups were similar to those shown in the MnT group. The FeDMnT and 
FeSMnT groups had higher Mn deposition in most brain regions so the MRI signal enhancement was likely due 
to Mn accumulation in the brain. 
 
 
 
One-way ANOVA and post-hoc range tests (see details above) were used to compare the difference of R1 and 
R2 values among the four groups in different brain regions. Average R1 and R2 values for the four groups and 
the results of the statistical tests are summarized in Table 2. 
 
Compared to the CN group, significant increases in R1 were observed in the MnT group in all brain regions (p < 
0.001) except the brainstem and cortex. No significant differences of R1 values were observed between the 
FeDMnT and FeSMnT groups in any of the examined brain regions. However, R1 values of the FeDMnT and 
FeSMnT groups were significantly larger than the values of CN and MnT groups (Table 2a,b). 
 
Significant differences in R2 between the CN and MnT groups were observed only in the striatum (p=0.01). No 
significant differences in R2 values were observed between the FeDMnT and FeSMnT groups in any of the 
brain regions except hippocampus (p = 0.03), while it approached significance in cerebellum (p = 0.07). The 
FeSMnT group showed increased R2 values in these regions compared to the FeDMnT group. Compared with 
the CN group, the FeDMnT and FeSMnT groups showed significant increases in R2 in the brainstem and 
striatum (p < 0.01). While no significant differences of R2 values were observed between the FeDMnT group 
and the MnT group in any of the brain regions except for the brainstem (p = 0.037), the FeSMnT group showed 
significant increase in multiple brain regions including the cortex, striatum and cerebellum (p < 0.01) compared 
to the MnT group. Detailed experimental results have been previously reported by Fitsanakis et al. (35). 
 
Model construction 
The experimental results revealed that both Mn and Fe concentrations measured by GFAAS, as well as the R1 
and R2 values, measured by MRI, varied across groups and across regions in a complicated way. Such effects 
imply that the relationship between relaxation rate and concentration may vary among tissues and complicate 
the use of relaxometry for estimating metal levels. We therefore evaluated two questions: (a) What is the 
relationship between the Mn (and/or Fe) concentration and R1 (and/or) R2? (b) Is MRI a reliable methodology to 
predict the metal concentrations in the brain? We used two different models to answer these questions. 
 
Linear model 
In simple aqueous solutions a linear relationship exists between the concentration of a paramagnetic species and 
the relaxation rate R1 (1/T1) and R2 (1/T2): 
 
R1,2 ([Ion]) = R1,2(0) + r1,2[Ion] (1) 
 
where R1,2([Ion]) is the MRI measured relaxation rate at a given concentration of paramagnetic ion and r1,2 is the 
so-called relaxivity. Taking Mn
2+
 as an example, R1,2(0) is the water proton relaxation rates without Mn
2+,
 and 
the constant r1,2 can be determined by fitting experimental data to eqn (1) (4,5,36). Thus, tissues with higher 
concentrations of Mn should have shorter relaxation times and show higher signal intensity in T1-weighted 
images, and lower signal intensity in T2-weighted images. Note that the absolute quantification of Mn levels is 
not straightforward because the relaxivity r is not an intrinsic property of the metal ion alone. The relaxivity 
may change with the specific molecular form and environment in which the metal resides. For example, it may 
increase as a result of binding to intracellular ligands (5,37), or it may decrease if the metal’s electron structure 
is altered or water access to the metal is restricted, as occurs in many molecular configurations. Quantification 
of the ratio r2/r1 may also provide insights into the chemical form of the metal (5).  
 
Control (CN) and Mn-treated with normal diet (MnT) groups. As shown in the experimental results, no 
difference in Fe concentrations existed between the control and the Mn-treated with normal diet (MnT) groups 
in any of the brain regions (Table 1b). For these two groups, we assumed that changes in Mn concentrations 
were the main contribution to the changes in the MR relaxation rates. Thus, the above linear model (eqn 1) was 
first applied only to these two groups. 
 
As illustrated in Fig. 2a,b the relaxation rates in most tissues in the CN and MnT groups increased linearly with 
increased Mn levels. The slopes (the effective relaxivities), however, varied in different regions and were all 
much smaller than the relaxivities of simple aqueous solutions. Midbrain and cortex showed negative r1 and r2 
values respectively, which has no physical meaning, though the correlations between relaxation rate and 
concentration were not significant (Table 3a,b). In addition, the ratio of R2 relaxivity (r2) to R1 relaxivity (r1) 
also varied among tissues and it was less than the ratio of the aqueous solution in all brain regions (Table 3c). 
 
 
The increases in relaxation rates were likely due to the deposition of Mn in the brain, though other contributions 
might be present, for example, from associated changes in Fe. The observation that Mn relaxivity varied among 
regions suggests the metal exists in different forms, or is physically confined to different degrees in different 
areas. Conversion of Mn
2+
 to another oxidation state of the metal, the presence of different substrates for 
binding, the effects of competition from other metals, as well as the variation in micro-viscosity, may all 
influence the relaxivity (5,37). Similarly, the r2/r1 ratio suggests there are differences in chemical form and 
binding effects. In the hippocampus, the R1 and R2 relaxivity were both small, although the metal levels there 
were relatively high. This implies that the relaxation effect of the Mn as a paramagnetic ion is largely decreased, 
as would be expected if Mn
2+
 is converted to a less paramagnetic state or if water access to the ion is restricted. 
These regional variations may be important for the interpretation of MR methods in use for tracking neural 
connectivity and for the use of MRI for monitoring metal deposition in tissues. 
 
All four groups. When the dietary Fe levels were varied, the amount of both Mn and Fe in the brain changed, as 
shown in Table 1. The absolute levels of Fe did not necessarily agree with the expected amounts from dietary 
intake, but for the purposes of determining how the levels of the two metals varied compared to each other, we 
needed only to achieve differing levels of the respective metals. We tried to test the utility of the linear model in 
two ways. First, relaxation rates were plotted against Mn and Fe concentrations separately using eqn (1). The 
fitting results are shown in Figure 2c–f and summarized in Table 4. Second, we assumed that both Mn and Fe 
independently exist in the brain, so that the relaxation rates measured by MRI are just a linear combination of 
their contributions, as shown in eqns (2) and (3). The least squares fitting method was applied to find the 
coefficients with the minimum residual. The results are summarized in Table 5. 
 
R1 ([Mn]; [Fe]) = R1 (0) + r1, Mn [Mn] + r1 ;Fe [Fe]  (2) 
 
R2([Mn]; [Fe]) = R2 (0) + r2, Mn [Mn] + r2;Fe[Fe]  (3) 
 
As shown in Fig. 2c–f and Tables 4 and 5, the estimated apparent longitudinal relaxivities of Fe were negative 
for most of the brain regions, which has no clear physical interpretation. 
 
Most of these negative values are highly significant as the corresponding p (significance) values are much 
smaller than 0.05 (Tables 4 and 5). These data indicate these negative values were mainly due to inappropriate 
application of the linear model and its incapacity to deal with simultaneous variations in two paramagnetic ions 
at the same time. The failure of the linear model and the results of GFAAS both suggested that Mn and Fe 
interact competitively and their combined influence on relaxation rates are more complicated than can be 
predicted with such a simple model. 
Competition model 
We propose a new model (Fig. 3 and eqns 4–12) to explain and interpret the combined influence of Mn and Fe 
on tissue relaxation rates. As illustrated in Fig. 3, we assume Mn and Fe compete for a common specific binding 
site or a set of sites. We also assume that in a given brain region, Mn or Fe can either be bound to this common 
binding site (MnB or FeB) or be ‘else’ (called MnE or FeE), as shown in eqns (6) and (7). Here, the ‘else’ ions 
include free ions and ions that bind to other substrates without competition. When either MnE or FeE 
successfully binds to a free common binding site (BSfree), they become MnB (1 Mn ion plus 1 common binding 
site) or FeB (1 Fe ion plus 1 common binding site), as shown in eqns (4) and (5).  
 
In a steady state, chemical equilibrium will be achieved between free ions, bound ions and common binding 
sites (eqns 4 and 5). The two equilibrium constants Keq,Mn and Keq,Fe are used to describe the chemical 
equilibrium for Mn and Fe respectively (eqns 9 and 10). The total number of common binding sites (BStotal) is 
the summation of three parts: free binding sites (BSfree), sites that bind to Mn (as in MnB) and sites that bind to 
Fe (as in FeB), as shown in eqn (8). Mntotal and Fetotal are the total Mn and Fe metals contents measured by 
GFAAS. The longitudinal and transverse relaxation rates R1 and R2 are a linear combination of the effects of 
MnB, FeB, MnE, and FeE as described by eqns (11) and (12). The parameters in eqns (6)–(12) can be estimated 
by a least-squares method. First, a set of initial values are given, then the nonlinear equations are solved by the 
Levenberg–Marquardt method (38) using the initial values of parameters and the values of measured Mn and Fe 
concentrations for each individual rat. Next, R1(0) and relaxivities are fitted using the measured R1 data 
according to eqn (11). The algorithm is a subspace trust region method and is based on the interior-reflective 
Newton method described in Ref. (39). Once the convergence criteria are met and the eight parameters (Keq,Mn, 
Keq,Fe, [BStotal], R1(0), r1,MnB, r1,MnE, r1,FeB, r1,FeE) are updated, the above procedure is repeated until a local 
minimum of residual error is found. Boundaries were set for the relaxivities during the fitting procedure to 
assure that their values are positive. The nonlinear fitting procedure in the proposed method requires careful 
consideration of initial parameter values and boundaries, which are common requirements for nonlinear 
optimization problems in mathematics. Additionally, as stated previously, the negative relaxivity has no 
physical meaning and accordingly must be properly handled to ensure computational validity. No convergence 
problems were encountered during the fitting procedures or the calculations. The stability/ reproducibility 
depends on the initial values of the fitting parameters, which is a common problem for most of the nonlinear 
fitting models. The existence of local minima affects the reproducibility of fitting with different initial values. 
The Monte Carlo simulation scheme is used to randomly set initial values and to search for the global 
minimum. Best simulation results are chosen based on statistical parameters, that is, R2 of the fitting procedure. 
This makes the proposed methodology more robust and objective. 
 
After the R1 fitting procedure is accomplished and eqns (6)–(1 1) are solved, MnB, MnE, FeB, and FeE 
concentrations are derived for each rat. Transverse relaxivities are then calculated using eqn (12). We chose to 
fit eqn (11) first rather than 12 based on the following rationale: First, the longitudinal relaxation rate correlates 
with Mn and Fe concentrations better than the transverse relaxation rate (Fig. 2 and Tables 3–5). This effect is 
consistent with what has been reported in the literature. For example, Southon et al. (40) reported that, in rat 
liver and pig organs, both MnDPDP and MnCl2 produced a positive dose-response in R1 and tissue Mn 
concentration, and only small or no response in R2. The effect of Fe on the transverse and longitudinal 
relaxation rates is complicated and has been reported in the literature in different ways. Although Fe is believed 
to be an effective T2 weighted contrast agent, it has been reported that Fe (III) changes T2 < T1 (41). Multiple 
factors like the pH, ion-binding capacity and the chemical form of the ion can influence effect of metal ions on 
proton relaxation in a complicated fashion. The fact that T1 maps (256 x 256) have higher resolution than T2 
maps (128 x 128) is another reason for us to select R1 instead of R2. The fitting results are summarized in Tables 
6 and 7. 
 
As shown in Table 6, the increase in relaxation rates was most likely due to the bound Mn and bound Fe since 
the relaxivities of FeE and MnE were very small, suggesting chemical modification and/or compartmentation. 
In Table 6, the symbol ―Null’ indicates the fitting parameter value is zero. It appears that the effect of MnB is 
significant for both r1 and r2 in all brain regions. In most of the brain regions, Mn that was bound to the common 
binding site showed a larger relaxation effect than the bound Fe, as r1 and r2 of MnB were much larger than the 
ones for FeB. The effect of FeE is not significant in most of the brain regions, except in the cortex. In the 
striatum and brainstem, the longitudinal and transverse relaxivities of Fe (both FeB and FeE) were zero, 
suggesting that Fe may have existed in a nonparamagnetic state or its paramagnetic character was largely 
diminished in these brain regions. The r1 relaxivities of bound Fe in the hippocampus were much larger than in 
the other brain regions. Due to limited data, a more rigorous statistical analysis requires future theoretical and 
experimental work. 
 
The predicted regional tissue concentrations of MnB, MnE, FeB, and FeE were also derived for each rat. The 
averaged values for CN, MnT, FeSMnT and FeDMnT groups are summarized in Table 7. Regional variations 
were also observed. For example, in the midbrain, most of the common binding sites were occupied by both Mn 
and Fe. In cerebellum, most of the common binding sites were occupied by Fe in all four groups (CN, MnT, 
FeSMnT, FeDMnT). The amount of FeB and MnB was consistent among the four groups while the FeE 
concentration decreased more than 85% in FeSMnT and FeDMnT groups compared to CN and MnT groups. 
The hippocampus was different from other regions as the ratio of [MnB]/[FeB] approximated 1:1, and it was 
consistent for all four groups. In addition, most of the Fe in the hippocampus was not bound to the common 
binding sites. 
 
Figure 4 shows the fitting results of the interacting model. The measured and predicted relaxation rates in all 
brain regions were plotted against ion concentrations (Fig. 4a–d). In addition, predicted relaxation rates in all 
brain regions were plotted against measured values (Fig. 4e and f). The nonlinear relationships between 
relaxation rates and [Mn] as well as relaxation rates with [Fe] appear to be well explained by this model. Note 
that the transverse relaxation rate is less well fitted than the longitudinal relaxation rate (Fig. 4e and f). 
 
 
 
DISCUSSION 
Comparison of the competition model with the linear models 
The fits to the data for the linear and competition models have been compared. The corresponding correlation 
coefficient, 95% confidence interval of the correlation coefficient as well as the p values are summarized in 
Table 8. Also, the regressions for all brain regions for all four models (competition model, linear model with 
both Mn and Fe considered, linear model with only Mn considered, linear model with only Fe considered) are 
plotted in Fig. 5. As illustrated in Fig. 5a, the competition model and the linear model with Mn and Fe fitted 
together using eqn (2) provided the best r
2
 in all of the brain regions. In some brain regions the fits derived by 
these two models are significantly improved over the other two linear models in which only one ion is 
considered (eqn 1). For example, for striatum the correlation coefficients derived by the competition and the 
linear models with both Mn and Fe considered are 0.87 and 0.85 respectively, while the values for the other two 
linear models with either Mn or Fe considered are 0.69 and 0.02 with 95% confidence interval of [0.36,0.86] 
and [—0.42, 0.45] respectively. Other brain regions, like brainstem and midbrain, also provide evidence that the 
competition and the linear models, taking into account both Mn and Fe, provide better fitting results than one or 
both of the other two linear models. There is no significant difference between the correlation coefficients of the 
competition model and the linear model with both Mn and Fe counted. However, as shown above, the 
relaxivities of Fe fitted with the linear model are significantly negative in almost all of the brain regions (Table 
5) which does not have any physical meaning. Thus, considering one metal alone at a time or both metals acting 
independently fails either to provide physically interpretable fits or to fit the data very successfully. Only by 
considering the competitive model are reasonable fits that have physical meanings obtained. 
 
 
 
The supplied chow for the different groups of rats all came from the same source (BioServe) and is formulated 
according to the AIN-93 guidelines for rodent chow to ensure proper health. The metal/mineral content was 
analyzed prior to shipment. Accordingly, the reported values are deemed reliable. A diet with Fe overload is 
known to increase Fe accumulation in the plasma (42). The increased brain Mn concentration accompanied by 
decreased brain Fe concentration with Fe supplemented in diet is surprising. This may be due to the fact that the 
added Mn that is on board in the FeSMnT group is more readily taken into the brain, offsetting the Fe overload 
in the diet. Alternatively, it is possible that Fe overload in the cells prevents the extracellular extrusion of Mn. 
Fe is transported extracellularly by ferroportin, and it has yet to be determined whether Mn shares the same 
transporter. If so, the Mn that is in the cells may be trapped due to the abundant Fe concentration in animals 
treated with fortified Fe diet, accounting for increased brain Mn levels in conditions of Fe repletion. This is well 
beyond the scope of this manuscript, but studies to assess the possibility are currently under way. 
 
Similar studies where rats were overloaded with dietary Fe for extended periods of time have been associated 
with approximately 10-fold increases in plasma Fe levels (43,44). This is likely due to the inability of the 
regulatory mechanisms to accurately adapt to the brain’s Fe requirements, due to transport and storage of Fe in 
ferritin. Normally, in the presence of exceedingly high levels of Fe, the regulatory pathway perceives the central 
nervous system as Fe deficient, despite excessive Fe accumulation, and Fe uptake into the brain continues. 
When Fe regulatory protein-1 (IRP1) and IRP2 bind to the Fe regulatory element (IRE) in the 3'-untranslated 
region of transferrin receptor (TfR) or DMT1 mRNA, the transcript is stabilized, translation proceeds, and the 
proteins are synthesized. Thus, a high IRP binding activity reflects low body Fe stores and results in up-
regulation of DMT1 and TfR. Vice versa, high intracellular Fe concentrations are predicted to have an opposite 
effect. Nonetheless, it is possible that down-regulation of DMT1 and TfR is associated with up-regulation of 
transporters that are Mn-specific. Thus even in the presence of high Fe, the uptake of Mn may continue 
unabated. It has also been reported by Chua and Morgan that iron overload and deficiency led to increased brain 
Mn (17). 
 
 
Regional variation of the relaxivities and combined influence of Mn and Fe on MRI signal 
One of our observations is that Mn and Fe relaxivities varied among various brain regions, suggesting that these 
metals exist in different forms or bind to different substrates. For example, the relaxivity of Mn can be 
decreased when Mn
2+
 is converted to a less paramagnetic state or if water access to the ion is restricted. The 
relaxation properties of iron can also be varied as its putative storage protein, ferritin, has different clustering 
stages and the concentration of ferritin varies in different brain regions (45,46). The effects of competition from 
other metals, as well as the variation in micro-viscosity may all influence the metal relaxivity (5,37). 
 
The effects of Mn and Fe on MR relaxation rates have been studied before in isolation and without 
consideration of the potential interaction between the two (27–29,31). Thus, when studies are designed to 
examine the effect of Mn on relaxivities, no other metal ions are usually considered. Conversely, other studies 
that focus solely on Fe have failed to take into account the interrelationship of this metal with Mn. As a result, 
most researchers have used a linear model to explain the influence of paramagnetic ions on the MRI signal. Our 
results show that when only one paramagnetic ion concentration change occurs, the simple linear model may 
appear to explain the relationship between ion concentration and relaxation rates. Thus the relaxation rate 
measured by MRI can be used as an indicator of ion concentration for this case. However, even with this simple 
linear model, the relaxivities vary among regions, implying that different brain regions should be treated 
separately rather than taking the whole brain as a single homogeneous region. To our knowledge, our study is 
the first one to examine the regional variation of the relaxivities. 
 
Although Mn and Fe are commonly studied together in the toxicology field, no MRI study was found in the 
literature to report on the combined influence of Mn and Fe on MRI signals. Our study is the first one to 
investigate this effect. Our results reveal that when more than one paramagnetic ion concentration is changing, 
the linear model does not describe the effects properly. As a result, a more complicated model must be applied. 
We propose an interacting model based on the fact that Mn and Fe may compete in vivo and both of them will 
affect MRI signals (5,21,37). These important regional variation effects are still very apparent in the interacting 
model. 
 
CONCLUSION 
It has been shown above, when Mn and Fe concentrations are both altered in a biological system, that their 
combined influence on MRI signals is complicated. In such a case, the simple linear model for explaining the 
relationship between MRI signal and a single changed paramagnetic ion will not be suitable to explain the 
change in MRI relaxation rates. Regional variations are apparent in both the experimental data and the model. 
Although the proposed competition model, like most nonlinear optimization problem, has its limitations and 
uncertainty, such as careful selection of initial parameter values and boundaries, proper convergence criteria for 
the balance of computational cost and accuracy, global and local minimum, this represents a first attempt to 
explain the interacting relationship of two paramagnetic ions and their influence on the MRI signals. Our model 
correctly predicts the nonlinear relationship between relaxation rates and ion contents. This model may be 
useful for interpreting MR results when more than one paramagnetic species is involved. 
 
Note: 
Abbreviations used: 95% CI, 95% confidence interval; BS, brainstem; BStotal, total number of common 
binding sites; BSfree, free binding sites; CB, cerebellum; CC, correlation coefficient; CX, cortex; CN, control 
group; DG, dentate gyrus; FeB, bound iron (binds to a common binding site); FeDMnT, manganese treated 
group fed with iron deficient food; FeE, iron exists in other format (either free or binds to uncommon binding 
site); FeSMnT, manganese treated group fed with iron supplemented food; FOV, field of view; Hb, habenula; 
HDL, high density lipoprotein; HP, hippocampus; Keq, equilibrium constant; MB, midbrain; MnB, bound 
manganese (binds to a common binding site); MnE, manganese exists in other format (either free or binds to 
uncommon binding site); MnT, manganese treated group with normal diet; MRI, magnetic resonance imaging; 
pons, pontine nuclei; ST, striatum. 
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